Concepedia
Statistics
Publications
24
Citations
741
H-Index
17
Active since
2012
Affiliations
Central South University(Current)
Xiangya Hospital Central South University
Sixth Affiliated Hospital of Sun Yat-sen University
Sun Yat-sen University
Central China Normal University
Dong Ding is an author at Central South University specializing in cost-effectiveness analysis, oncology, and cost-effectiveness.
Publications per year
2012–2024
Cost-Effectiveness Analysis of Durvalumab Plus Chemotherapy in the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer
Dong Ding, Huabin Hu, Shuosha Li et al. · Journal of the National Comprehensive Cancer Network · 2021 · 93 citations · Full text
Pharmacy, Oncology, Pharmacoeconomics +17
Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greater
Longjiang She, Huabin Hu, Mengting Liao et al. · Lung Cancer · 2019 · 59 citations
Medicine, Oncology, Pharmacoeconomics +16
Experimental animal models of pulmonary hypertension: Development and challenges
Jie‐Ling Ma, Dong Ding, Yuejiao Ma et al. · Animal Models and Experimental Medicine · 2022 · 59 citations · Full text
Life Sciences, Cardiology, Physiology +17
Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
Huabin Hu, Longjiang She, Mengting Liao et al. · Frontiers in Oncology · 2020 · 49 citations · Full text
Pembrolizumab Plus Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A Cost-Effectiveness Analysis
Youwen Zhu, Kun Liu, Dong Ding et al. · Advances in Therapy · 2022 · 49 citations
Medicine, Oncology, Pharmacoeconomics +14
1–5 of 24